MAIA Biotechnology, Inc. MAIA
1.20
(0.05)
(4.00%)
as of 25 Sep
- Market cap
- $76.0M
- P/E
- 0.0×
Follow MAIA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (218.68%) | (148.29%) | (745.24%) | (2,691.01%) |
+8 more TTM periods Free account |
|
| (136.67%) | (102.78%) | (225.54%) | (212.51%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(122.14%) | (83.64%) | (579.39%) | (1,268.92%) | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(0.37) | (0.44) | (0.59) | (0.47) | |
Free Cash Flow |
(22.57) | (19.95) | (18.84) | (15.73) | |
Piotroski F-Score |
3.00 | 3.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(46.75%) | (32.09%) | (170.79%) | (143.89%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.82 | 0.84 | 0.70 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.37) | (0.44) | (0.59) | (0.47) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates